Literature DB >> 19274657

Translocation through the nuclear pore: Kaps pave the way.

Reiner Peters1.   

Abstract

Transport through the nuclear pore complex (NPC), a keystone of the eukaryotic building plan, is known to involve a large channel and an abundance of phenylalanine-glycine (FG) protein domains serving as binding sites for soluble nuclear transport receptors and their cargo complexes. However, the conformation of the FG domains in vivo, their arrangement in relation to the transport channel and their function(s) in transport are still vividly debated. Here, we revisit a number of representative transport models-specifically Brownian affinity gating, selective phase gating, reversible FG domain collapse, and reduction of dimensionality (ROD)-in the light of new data obtained by optical single transporter recording, optical superresolution microscopy, artificial nanopores, and many other techniques. The analysis suggests that a properly adapted, simplified version of the ROD model accounts well for the available data. This has implications for nucleocytoplasmic transport in general.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19274657     DOI: 10.1002/bies.200800159

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  55 in total

1.  Nucleocytoplasmic transport: a role for nonspecific competition in karyopherin-nucleoporin interactions.

Authors:  Jaclyn Tetenbaum-Novatt; Loren E Hough; Roxana Mironska; Anna Sophia McKenney; Michael P Rout
Journal:  Mol Cell Proteomics       Date:  2012-02-22       Impact factor: 5.911

Review 2.  The nuclear envelope.

Authors:  Martin W Hetzer
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

3.  A bimodal distribution of two distinct categories of intrinsically disordered structures with separate functions in FG nucleoporins.

Authors:  Justin Yamada; Joshua L Phillips; Samir Patel; Gabriel Goldfien; Alison Calestagne-Morelli; Hans Huang; Ryan Reza; Justin Acheson; Viswanathan V Krishnan; Shawn Newsam; Ajay Gopinathan; Edmond Y Lau; Michael E Colvin; Vladimir N Uversky; Michael F Rexach
Journal:  Mol Cell Proteomics       Date:  2010-04-05       Impact factor: 5.911

Review 4.  The nuclear pore complex: bridging nuclear transport and gene regulation.

Authors:  Caterina Strambio-De-Castillia; Mario Niepel; Michael P Rout
Journal:  Nat Rev Mol Cell Biol       Date:  2010-07       Impact factor: 94.444

5.  Structures of the tRNA export factor in the nuclear and cytosolic states.

Authors:  Atlanta G Cook; Noemi Fukuhara; Martin Jinek; Elena Conti
Journal:  Nature       Date:  2009-09-03       Impact factor: 49.962

Review 6.  Flexible gates: dynamic topologies and functions for FG nucleoporins in nucleocytoplasmic transport.

Authors:  Laura J Terry; Susan R Wente
Journal:  Eukaryot Cell       Date:  2009-10-02

7.  Simulations of nuclear pore transport yield mechanistic insights and quantitative predictions.

Authors:  Joshua S Mincer; Sanford M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

8.  Biophysical coarse-grained modeling provides insights into transport through the nuclear pore complex.

Authors:  R Moussavi-Baygi; Y Jamali; R Karimi; M R K Mofrad
Journal:  Biophys J       Date:  2011-03-16       Impact factor: 4.033

Review 9.  Protein Transport by the Nuclear Pore Complex: Simple Biophysics of a Complex Biomachine.

Authors:  Tijana Jovanovic-Talisman; Anton Zilman
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

10.  Structure, dynamics, evolution, and function of a major scaffold component in the nuclear pore complex.

Authors:  Parthasarathy Sampathkumar; Seung Joong Kim; Paula Upla; William J Rice; Jeremy Phillips; Benjamin L Timney; Ursula Pieper; Jeffrey B Bonanno; Javier Fernandez-Martinez; Zhanna Hakhverdyan; Natalia E Ketaren; Tsutomu Matsui; Thomas M Weiss; David L Stokes; J Michael Sauder; Stephen K Burley; Andrej Sali; Michael P Rout; Steven C Almo
Journal:  Structure       Date:  2013-03-14       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.